These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7532455

  • 1. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX.
    Lees GJ, Leong W.
    Neuroreport; 1994 Oct 27; 5(16):2153-6. PubMed ID: 7532455
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of NBQX on the distal and local toxicity of glutamate agonists administered intra-hippocampally.
    Lees GJ, Leong W.
    Brain Res; 1993 Nov 19; 628(1-2):1-7. PubMed ID: 7508807
    [Abstract] [Full Text] [Related]

  • 3. Synergy between diazepam and NBQX in preventing neuronal death caused by non-NMDA agonists.
    Lees GJ, Leong W.
    Neuroreport; 1994 Oct 27; 5(16):2149-52. PubMed ID: 7532454
    [Abstract] [Full Text] [Related]

  • 4. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
    Parsons CG, Gruner R, Rozental J.
    Neuropharmacology; 1994 May 27; 33(5):589-604. PubMed ID: 7523977
    [Abstract] [Full Text] [Related]

  • 5. Neuronal damage induced by beta-N-oxalylamino-L-alanine, in the rat hippocampus, can be prevented by a non-NMDA antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
    Willis CL, Meldrum BS, Nunn PB, Anderton BH, Leigh PN.
    Brain Res; 1993 Nov 05; 627(1):55-62. PubMed ID: 7507397
    [Abstract] [Full Text] [Related]

  • 6. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
    Massieu L, Tapia R.
    Neuroscience; 1994 Apr 05; 59(4):931-8. PubMed ID: 7520137
    [Abstract] [Full Text] [Related]

  • 7. The non-NMDA glutamate antagonist NBQX blocks the local hippocampal toxicity of kainic acid, but not the diffuse extrahippocampal damage.
    Lees GJ, Leong W.
    Neurosci Lett; 1992 Aug 31; 143(1-2):39-42. PubMed ID: 1331904
    [Abstract] [Full Text] [Related]

  • 8. Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists.
    Berg M, Bruhn T, Johansen FF, Diemer NH.
    Pharmacol Toxicol; 1993 Nov 31; 73(5):262-8. PubMed ID: 8115308
    [Abstract] [Full Text] [Related]

  • 9. Non-NMDA antagonists protect against kainate more than AMPA toxicity in the rat hippocampus.
    Moncada C, Arvin B, Le Peillet E, Meldrum BS.
    Neurosci Lett; 1991 Dec 09; 133(2):287-90. PubMed ID: 1816508
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological characterization of non-NMDA subtypes of glutamate receptor in the neonatal rat hemisected spinal cord in vitro.
    Zeman S, Lodge D.
    Br J Pharmacol; 1992 Jun 09; 106(2):367-72. PubMed ID: 1382781
    [Abstract] [Full Text] [Related]

  • 11. Blocking the trigeminal EPSP in rat abducens motoneurons in vivo with the AMPA antagonists NBQX and GYKI 53655.
    Ruiz A, Durand J.
    Brain Res Bull; 2000 May 15; 52(2):99-107. PubMed ID: 10808079
    [Abstract] [Full Text] [Related]

  • 12. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
    Liljequist S, Cebers G, Kalda A.
    Biochem Pharmacol; 1995 Nov 27; 50(11):1761-74. PubMed ID: 8615854
    [Abstract] [Full Text] [Related]

  • 13. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K.
    J Pharmacol Exp Ther; 1996 Jan 27; 276(1):84-92. PubMed ID: 8558460
    [Abstract] [Full Text] [Related]

  • 14. Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.
    Ohno K, Okada M, Tsutsumi R, Matsumoto N, Yamaguchi T.
    Neurochem Int; 1998 Mar 27; 32(3):265-71. PubMed ID: 9587920
    [Abstract] [Full Text] [Related]

  • 15. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes.
    Okada M, Kohara A, Yamaguchi T.
    Eur J Pharmacol; 1996 Aug 15; 309(3):299-306. PubMed ID: 8874154
    [Abstract] [Full Text] [Related]

  • 16. In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466.
    Lees GJ, Leong W.
    Brain Res; 2001 Jan 26; 890(1):66-77. PubMed ID: 11164769
    [Abstract] [Full Text] [Related]

  • 17. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury.
    Koh S, Tibayan FD, Simpson JN, Jensen FE.
    Epilepsia; 2004 Jun 26; 45(6):569-75. PubMed ID: 15144420
    [Abstract] [Full Text] [Related]

  • 18. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L.
    Br J Pharmacol; 1998 Nov 26; 125(6):1258-66. PubMed ID: 9863655
    [Abstract] [Full Text] [Related]

  • 19. Effects of glutamate receptor agonists and antagonists on Ca2+ uptake in rat hippocampal slices lesioned by glucose deprivation or by kainate.
    Alici K, Gloveli T, Schmitz D, Heinemann U.
    Neuroscience; 1997 Mar 26; 77(1):97-109. PubMed ID: 9044378
    [Abstract] [Full Text] [Related]

  • 20. Chronic exposure of kainate and NBQX changes AMPA toxicity in hippocampal slice cultures.
    Jakobsen B, Zimmer J.
    Neuroreport; 2001 Nov 16; 12(16):3593-7. PubMed ID: 11733718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.